115 related articles for article (PubMed ID: 27801454)
1. Reversibility of the thia-Michael reaction of cytotoxic C
Kohyama A; Fukuda M; Sugiyama S; Yamakoshi H; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
Org Biomol Chem; 2016 Dec; 14(45):10683-10687. PubMed ID: 27801454
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationships of the Antitumor C5-Curcuminoid GO-Y030.
Kohyama A; Yamakoshi H; Hongo S; Kanoh N; Shibata H; Iwabuchi Y
Molecules; 2015 Aug; 20(8):15374-91. PubMed ID: 26305242
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Water-Soluble Prodrugs of C5-Curcuminoid GO-Y030 Based on Reversible Thia-Michael Reaction.
Yamakoshi H; Fukuda M; Ikeda H; Fujiki S; Kohyama A; Nagasawa S; Shinozaki H; Shibata H; Iwabuchi Y
Chem Pharm Bull (Tokyo); 2024; 72(1):127-134. PubMed ID: 38296515
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
Yamakoshi H; Ohori H; Kudo C; Sato A; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
Bioorg Med Chem; 2010 Feb; 18(3):1083-92. PubMed ID: 20060305
[TBL] [Abstract][Full Text] [Related]
5. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.
Lin L; Liu Y; Li H; Li PK; Fuchs J; Shibata H; Iwabuchi Y; Lin J
Br J Cancer; 2011 Jul; 105(2):212-20. PubMed ID: 21694723
[TBL] [Abstract][Full Text] [Related]
6. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
[TBL] [Abstract][Full Text] [Related]
7. Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo.
Shibata H; Yamakoshi H; Sato A; Ohori H; Kakudo Y; Kudo C; Takahashi Y; Watanabe M; Takano H; Ishioka C; Noda T; Iwabuchi Y
Cancer Sci; 2009 May; 100(5):956-60. PubMed ID: 19445025
[TBL] [Abstract][Full Text] [Related]
8. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.
Kudo C; Yamakoshi H; Sato A; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Anticancer Res; 2011 Nov; 31(11):3719-26. PubMed ID: 22110192
[TBL] [Abstract][Full Text] [Related]
9. Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity.
Schmitt F; Subramaniam D; Anant S; Padhye S; Begemann G; Schobert R; Biersack B
ChemMedChem; 2018 Jun; 13(11):1115-1123. PubMed ID: 29570947
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxicity against human oral cancer KB cells and structure-activity relationship studies of trienone analogues of curcuminoids.
Chuprajob T; Changtam C; Chokchaisiri R; Chunglok W; Sornkaew N; Suksamrarn A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2839-44. PubMed ID: 24857542
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the pharmacophore of curcumin. Which structural element is critical for which action?
Minassi A; Sánchez-Duffhues G; Collado JA; Muñoz E; Appendino G
J Nat Prod; 2013 Jun; 76(6):1105-12. PubMed ID: 23742639
[TBL] [Abstract][Full Text] [Related]
12. Novel Conjugated Unsaturated Ketones with Submicromolar Potencies Towards some Leukemic and Colon Cancer Cells.
Das S; Gul HI; Das U; Balzarini J; Dimmock SG; Dimmock JR
Med Chem; 2019; 15(4):430-438. PubMed ID: 30324886
[TBL] [Abstract][Full Text] [Related]
13. Are the Cytotoxic Properties of Conjugated Unsaturated Ketones Inactivated by Thiols?
Doroudi A; Roayapalley PK; Das S; Das U; Dimmock JR
Pharmazie; 2023 Jul; 78(6):82-85. PubMed ID: 37537771
[TBL] [Abstract][Full Text] [Related]
14. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
[TBL] [Abstract][Full Text] [Related]
15. Structural factors affecting cytotoxic activity of (E)-1-(Benzo[d ][1,3]oxathiol-6-yl)-3-phenylprop-2-en-1-one derivatives.
Konieczny MT; Bułakowska A; Polak J; Pirska D; Konieczny W; Gryń P; Skladanowski A; Sabisz M; Lemke K; Pieczykolan A; Gałązka M; Wiciejowska K; Wietrzyk J
Chem Biol Drug Des; 2014 Jul; 84(1):86-91. PubMed ID: 24476543
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and anticancer activity of Michael-type thiol adducts of α-santonin analogue with exocyclic methylene.
Khazir J; Riley DL; Chashoo G; Mir BA; Liles D; Islam MA; Singh SK; Vishwakarma RA; Pilcher LA
Eur J Med Chem; 2015 Aug; 101():769-79. PubMed ID: 26222449
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
18. Hexamethoxylated Monocarbonyl Analogues of Curcumin Cause G2/M Cell Cycle Arrest in NCI-H460 Cells via Michael Acceptor-Dependent Redox Intervention.
Li Y; Zhang LP; Dai F; Yan WJ; Wang HB; Tu ZS; Zhou B
J Agric Food Chem; 2015 Sep; 63(35):7731-42. PubMed ID: 26255837
[TBL] [Abstract][Full Text] [Related]
19. The reaction of cinnamaldehyde and cinnam(o)yl derivatives with thiols.
Autelitano A; Minassi A; Pagani A; Taglialatela-Scafati O; Appendino G
Acta Pharm Sin B; 2017 Jul; 7(4):523-526. PubMed ID: 28752040
[TBL] [Abstract][Full Text] [Related]
20. Strong inhibitory effects of curcumin and its demethoxy analog on Escherichia coli ATP synthase F1 sector.
Sekiya M; Chiba E; Satoh M; Yamakoshi H; Iwabuchi Y; Futai M; Nakanishi-Matsui M
Int J Biol Macromol; 2014 Sep; 70():241-5. PubMed ID: 25010476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
